Denali Therapeutics (4DN.F) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.77
-0.69
-0.62
-0.55

Details

Expected EPS
-0.61399340415
Actual EPS
-0.687609
Surprise EPS
-0.07
Surprise Percent
+11.99%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.687609 per share for Q2 2025.

0 Comments

Share your thoughts